2002
DOI: 10.1590/s0036-46652002000400001
|View full text |Cite
|
Sign up to set email alerts
|

Morbidity and survival in advanced AIDS in Rio de Janeiro, Brazil

Abstract: SUMMARYOpportunistic diseases (OD) are the most common cause of death in AIDS patients. To access the incidence of OD and survival in advanced immunodeficiency, we included 79 patients with AIDS treated at Hospital Evandro Chagas (FIOCRUZ) from September 1997 to December 1999 with at least one CD4 count £ 100 cells/mm We found a very low incidence of OD and long survival after CD4 < 100 cells/mm 3 . Survival was significantly associated with restoration of baseline CD4 counts above 100 cells/mm 3 .

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
21
0
3

Year Published

2007
2007
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(27 citation statements)
references
References 15 publications
3
21
0
3
Order By: Relevance
“…Our study population displayed good adherence to treatment (88.5%), indicating increased survival and a reduced frequency in opportunistic diseases, including intestinal parasites. Several factors, such as service improvement and early diagnosis, in addition to HAART introduction, are involved in this scenario (44)(45)(46)(47). Some studies have linked nutritional status to intestinal parasitic infections (14,15,48).…”
Section: Discussionmentioning
confidence: 99%
“…Our study population displayed good adherence to treatment (88.5%), indicating increased survival and a reduced frequency in opportunistic diseases, including intestinal parasites. Several factors, such as service improvement and early diagnosis, in addition to HAART introduction, are involved in this scenario (44)(45)(46)(47). Some studies have linked nutritional status to intestinal parasitic infections (14,15,48).…”
Section: Discussionmentioning
confidence: 99%
“…3,23 Vários autores atribuem o aumento dessa sobrevida ao uso da terapia anti-retroviral, especialmente dos inibidores de protease. [5][6][7][8]11,12,33 Este estudo contou tão-somente com informações da vigilância epidemiológica e não lhe foi possível estimar o impacto do uso da medicação, tanto o acesso a ela como a adesão ao tratamento, na sobrevida do paciente.…”
Section: Metodologiaunclassified
“…Essa maior sobrevida também é associada a faixas etárias mais jovens, porém a importância do sexo nessa associação permanece controversa. [5][6][7][8] O início da terapia anti-retroviral a partir de 1996 melhorou substancialmente o tempo de sobrevida e o quadro clínico-laboratorial, além de reduzir internações das pessoas vivendo com HIV/aids. 3,[9][10][11][12] O acesso aos serviços de saúde -principalmente os de assistên-cia especializada -e a medicamentos, e dificuldades relativas à adesão ao tratamento ainda causam impacto negativo em sua sobrevida.…”
Section: Introductionunclassified
“…In patients diagnosed in 1995 and 1996, the mean survival increased to 18 and 58 months, respectively 4 . More recently, in 2002, a mean survival time of 7 years was reported 5 .…”
Section: Introductionmentioning
confidence: 99%
“…Several factors are implicated in the prolonged survival of patients with AIDS, including improved services, early diagnosis, the introduction of antiretroviral (ARV) therapy, laboratorial follow-up, and the values of markers of disease progression such as viral load and CD4 T lymphocytes 5 .…”
Section: Introductionmentioning
confidence: 99%